Skip to content

Endometriosis and ATR-FTIR Spectroscopy

Detection of Endometriosis Using ATR-FTIR Spectroscopy

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06426420
Enrollment
600
Registered
2024-05-23
Start date
2022-09-15
Completion date
2026-04-29
Last updated
2024-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriomas, Endometriosis

Keywords

Endometriosis, Diagnosis, Spectroscopy, FTIR, Urine, Detection, Infrared

Brief summary

The goal of this study is to explore the use of mid-infrared spectroscopy (ATR-FTIR) as a detection tool for endometriosis in urine.

Detailed description

Endometriosis is a chronic gynecological disease that is considered debilitating and multifactorial. Its diagnosis is invasive and can be prolonged due to non-specific symptoms and erroneous or late investigations, which can lead to delays and impair the provision of adequate treatment. ATR-FTIR Spectroscopy is a non-invasive technique with the capability to identify the chemical composition and molecular changes of samples through its interaction with mid-infrared radiation. The aim of this work is to develop a rapid test for the detection of endometriosis in urine samples using spectroscopy and machine learning algorithms.

Interventions

DIAGNOSTIC_TESTFTIR spectroscopy analysis

ATR-FTIR Spectroscopy analysis combined with machine learning algorithms.

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Federal University of Espirito Santo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Female * Pelvic pain complain

Exclusion criteria

* Age under 18 or above 55 * Lack of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Spectroscopy Reliability (diagnostic metrics)1 yearThe primary outcome is the evaluation of specificity, sensitivity and accuracy of the diagnostic. Acceptable diagnostic metrics must be comparable to MRI, which will demonstrate if spectroscopy can discriminate between negative and positive endometriosis patients.

Countries

Brazil

Contacts

Primary ContactValerio G Barauna, PhD
barauna2@gmail.com+5527996892407

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026